HSBC Holdings’s ALX Oncology ALXO Stock Holding History

HSBC Holdings’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.5K	Hold	10,105	–	–	﹤0.01%	2857
2025 Q4	$11.6K	Sell	10,105 -712	-7%	-$1.08K	﹤0.01%	2904
2025 Q3	$19.1K	Sell	10,817 -1,489	-12%	-$1.29K	﹤0.01%	2674
2025 Q2	$5.05K	Sell	12,306 -3,822	-24%	-$1.93K	﹤0.01%	3002
2025 Q1	$9.66K	Sell	16,128 -26	-0.2%	-$31	﹤0.01%	2987
2024 Q4	$25.6K	Buy	16,154 +2,235	+16%	+$3.44K	﹤0.01%	3043
2024 Q3	$25.7K	Buy	13,919 +3,139	+29%	+$11.7K	﹤0.01%	2931
2024 Q2	$62.6K	Buy	+10,780	New	+$133K	﹤0.01%	2799
2024 Q1	–	Sell	-17,793	Closed	-$263K	–	3043
2023 Q4	$263K	Sell	17,793 -17,611	-50%	-$167K	﹤0.01%	2344
2023 Q3	$168K	Buy	+35,404	New	+$192K	﹤0.01%	2457

Other funds holding ALXO

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

HSBC Holdings's ALXO Position: Q1 2026 in Review

HSBC Holdings held its ALX Oncology (ALXO) position steady in Q1 2026 at 10,105 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2857.

HSBC Holdings first reported a position in ALXO in Q3 2023 and has held it in 10 quarters since. The position peaked at $263K in Q4 2023. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

HSBC Holdings held 10,105 shares of ALX Oncology worth $20.5K as of Q1 2026.
HSBC Holdings left its ALX Oncology share count unchanged in Q1 2026.
ALX Oncology made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2857 holding.
HSBC Holdings first reported a position in ALX Oncology in Q3 2023 and has held it in 10 quarters since.
HSBC Holdings's ALX Oncology position peaked at $263K in Q4 2023.
69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.